ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide

Ann Intern Med. 2016 Jan 19;164(2):JC6. doi: 10.7326/ACPJC-2016-164-2-006.
No abstract available

Publication types

  • Comment

MeSH terms

  • Bronchodilator Agents / therapeutic use*
  • Humans
  • Ipratropium / therapeutic use*
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Scopolamine Derivatives / therapeutic use*
  • Tiotropium Bromide / therapeutic use*

Substances

  • Bronchodilator Agents
  • Scopolamine Derivatives
  • Ipratropium
  • Tiotropium Bromide